FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes [Internet]
Clinical trials have followed patients for multiple years without identifying new safety concerns that emerge with longer use
Notably, a poll indicates that 37% of individuals with chronic health issues need financial support, yet only 41% receive it, highlighting the importance of utilizing these options
I Am Taking a GLP-1 Weight-Loss MedicationWhat Should I Know? JAMA Internal Medicine , vol
The most common sleep-related effects include mild insomnia during dose escalation (affecting roughly 8% of users) and occasional vivid dreams, both of which typically resolve within 4 to 6 weeks
It lowers FGF21, a hormone associated with metabolic stress, which might indicate reduced strain on the liver